Matching ATP supply and demand in cardiac pacemaker cells
Matching ATP supply and demand in cardiac pacemaker cells
批准号:
8931611
负责人:
Edward Lakatta
金额:
$11.59万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Action PotentialsAdenosine TriphosphateAdenylate CyclaseCalmodulinCellsConsumptionCyclic AMPCyclic AMP-Dependent Protein KinasesFeedbackFlavoproteinsFluorescenceGlycolysis InhibitionHeartHomeostasisInterventionIsoproterenolLinkMeasuresMediatingMembraneMitochondriaMuscle CellsNatureOryctolagus cuniculusPhosphorylationPhysiologicalProductionProtein phosphataseProteinsPumpReceptor ActivationSalineSarcoplasmic ReticulumSignal TransductionSinoatrial NodeSurfaceSuspension substanceSuspensionsTissuesVentricularbeta-adrenergic receptorcalmodulin-dependent protein kinase IIdensityfallsfeedingmeetingsnodal myocytephosphoric diester hydrolaseresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In sinoatrial node cells (SANC), Ca2+ activates adenylate cyclase (AC) to generate a high basal level of cAMP-mediated/protein kinase A (PKA)-dependent phosphorylation and Ca2+/calmodulin-dependent protein kinase II (CaMKII) protein phosphorylation of Ca2+ cycling proteins. These result in spontaneous sarcoplasmic reticulum (SR)-generated rhythmic Ca2+ oscillations during diastolic depolarization that not only trigger the surface membrane to generate rhythmic action potentials (APs), but, in a feed-forward manner, also activate AC/PKA/CaMKII signaling. ATP is consumed to pump Ca2+ to the SR, to produce cAMP, to support contraction and to maintain cell ionic homeostasis. Since feedback mechanisms link ATP-demand to ATP production, we hypothesized that (1) both basal ATP supply and demand in SANC would be Ca2+-cAMP/PKA/CaMKII dependent. (2) Due to its feed-forward nature, a decrease in flux through the Ca2+-cAMP/PKA signaling axis will reduce the basal ATP production rate. (3) Basal state calmodulin-CaMKII signaling is also linked to basal ATP production rate. SANC possess a high mitochondrial density, similar to other heart tissues O2 consumption in spontaneous beating SANC was comparable to ventricular myocytes (VM) stimulated at 3 Hz. Graded reduction of basal Ca2+-cAMP/PKA/CaMKII signaling to reduce ATP demand in rabbit SANC produced graded ATP depletion, and reduced O2 consumption and flavoprotein fluorescence. Graded reductions in basal CaMKII activity also reduced the cAMP level. In contrast to SANC, reductions in ATP demand in VM do not appreciably change the steady ATP levels. Neither inhibition of glycolysis, selectively blocking contraction nor specific inhibition of mitochondrial Ca2+ flux reduced the ATP level. We can conclude that feed-forward basal Ca2+-cAMP/PKA/CaMKII signaling both consumes ATP to drive spontaneous APs in SANC and is tightly linked to mitochondrial ATP production. Interfering with Ca2+-cAMP/PKA /CaMKII signaling not only slows the firing rate and reduces ATP consumption, but also appears to reduce ATP production so that ATP levels fall. This distinctly differs from VM, which lack this basal feed-forward basal cAMP/PKA/CaMKII signaling, and in which the ATP level remains constant when the demand changes.
In response to beta-adrenergic receptor activation, the spontaneous AP firing rate and the demand for ATP increase. To increase ATP demand, single isolated rabbit SANC were superfused by physiological saline at 350.5C with isoproterenol, or by phosphodiesterase or protein phosphatase inhibition. We measured cytosolic and mitochondrial Ca2+ and flavoprotein fluorescence in single SANC and we measured cAMP, ATP and O2 consumption in SANC suspensions. Although the increase in spontaneous AP firing rate was accompanied by an increase in O2 consumption, the ATP level and flavoprotein fluorescence remained constant, indicating that ATP production had increased. Both Ca2+m and cAMP increased concurrently with the increase in AP firing rate. When Ca2+m was reduced by Ru360, the increase in spontaneous AP firing rate in response to isoproterenol was reduced by 25%. Thus, both an increase in Ca2+m and an increase in Ca2+ activated cAMP-PKA-CaMKII signaling regulate the increase in ATP supply to meet ATP demand above the basal level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Potential of EPO and its Derivatives for Reducing Blood Pressure
-
批准号:9147229
-
项目类别:
-
资助金额:$15.43万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
A PUFA Dietary Intervention for Heart Rate
-
批准号:8552336
-
项目类别:
-
资助金额:$29.25万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
The VALIDATE study
-
批准号:8736504
-
项目类别:
-
资助金额:$22.85万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
A PUFA Dietary Intervention for Heart Rate
-
批准号:8335786
-
项目类别:
-
资助金额:$25.83万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Decreased pacemaker activity in aged sinoatrial node
-
批准号:8335801
-
项目类别:
-
资助金额:$11.03万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
The REVEAL study
-
批准号:8552344
-
项目类别:
-
资助金额:$4.99万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
PDE3, PDE4 and PKC regulate local Ca2+ releases and cardiac pacemaker firing
-
批准号:8736511
-
项目类别:
-
资助金额:$20.67万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Effects Of Age And Conditioning Status On Rest And Exercise Cardiac Performance
-
批准号:8931601
-
项目类别:
-
资助金额:$6.47万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling
-
批准号:8931487
-
项目类别:
-
资助金额:$39.09万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling
-
批准号:9147247
-
项目类别:
-
资助金额:$38.59万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Reduction of myocardial damage during acute ischemia
-
批准号:9147361
-
项目类别:
-
资助金额:$15.15万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
The VALIDATE study
-
批准号:9356016
-
项目类别:
-
资助金额:$29.2万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
The VALIDATE study
-
批准号:9565899
-
项目类别:
-
资助金额:$7.86万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Beat to beat Ca2+-dependent regulation of pacemaker cell rate and rhythm
-
批准号:8335874
-
项目类别:
-
资助金额:$5.8万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Are SANC from the center or periperal area of the sinoatrial node different?
-
批准号:8335932
-
项目类别:
-
资助金额:$4.64万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Biochemistry and Signaling of Receptor for Advanced Glycation End Products
-
批准号:8335931
-
项目类别:
-
资助金额:$10.74万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Soluble Receptor for Advanced Glycation End Products for Therapeutic Application
-
批准号:8552494
-
项目类别:
-
资助金额:$12.3万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Non-coding RNAs (ncRNAs) in Cardiovascular Aging
-
批准号:10007350
-
项目类别:
-
资助金额:$13.66万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Both PKA and CaMKII phosphorylation drive pacemaker cell automaticity
-
批准号:10007330
-
项目类别:
-
资助金额:$43.7万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
Effect of Metalloprotease Inhibition on Age-Associated Arterial Remodeling
-
批准号:10259324
-
项目类别:
-
资助金额:$4.71万
-
财政年份:--
-
负责人:Edward Lakatta
-
依托单位:
海外基金